Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,002 | 207 | 98.0% |
| Education | $80.80 | 4 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $906.44 | 47 | $0 (2024) |
| ABBVIE INC. | $852.38 | 45 | $0 (2024) |
| Alkermes, Inc. | $720.07 | 39 | $0 (2024) |
| ITI, Inc. | $285.51 | 21 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $241.39 | 6 | $0 (2024) |
| Axsome Therapeutics, Inc. | $234.66 | 9 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $180.67 | 10 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $180.49 | 6 | $0 (2024) |
| Lundbeck LLC | $144.41 | 9 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $109.31 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,114 | 49 | ABBVIE INC. ($302.11) |
| 2023 | $1,449 | 65 | Otsuka America Pharmaceutical, Inc. ($299.01) |
| 2022 | $756.07 | 50 | Alkermes, Inc. ($184.87) |
| 2021 | $763.17 | 47 | AbbVie Inc. ($204.89) |
All Payment Transactions
211 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: CNS | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $7.90 | General |
| Category: CNS | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $22.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 09/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: PSYCHIATRY | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: CNS | ||||||
| 07/31/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: PSYCHIATRY | ||||||
| 07/30/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug), HETLIOZ | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: SCHIZOPHRENIA | ||||||
| 07/17/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: CNS | ||||||
| 06/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: PSYCHIATRY | ||||||
| 06/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: PSYCHIATRY | ||||||
| 06/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Neuroscience | ||||||
| 06/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: CNS | ||||||
| 06/16/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $61.13 | General |
| Category: Neuroscience | ||||||
| 06/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: NEUROSCIENCE | ||||||
About Mary Leyda, PMHNP-BC
Mary Leyda, PMHNP-BC is a Psychiatric/Mental Health healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2019. The National Provider Identifier (NPI) number assigned to this provider is 1619534146.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mary Leyda, PMHNP-BC has received a total of $4,083 in payments from pharmaceutical and medical device companies, with $1,114 received in 2024. These payments were reported across 211 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($4,002).
Practice Information
- Specialty Psychiatric/Mental Health
- Location Eugene, OR
- Active Since 05/21/2019
- Last Updated 02/04/2025
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1619534146
Products in Payments
- VRAYLAR (Drug) $844.69
- ARISTADA (Drug) $503.88
- CAPLYTA (Drug) $466.00
- ABILIFY MAINTENA (Drug) $434.38
- REXULTI (Drug) $379.85
- SPRAVATO (Drug) $241.39
- Auvelity (Drug) $234.66
- LYBALVI (Drug) $216.19
- HETLIOZ (Drug) $136.97
- ABILIFY MYCITE (Drug) $135.46
- INGREZZA (Drug) $109.31
- BRINTELLIX (Drug) $76.33
- LATUDA (Drug) $73.98
- ABILIFY ASIMTUFII (Drug) $51.77
- COBENFY (Drug) $49.27
- FANAPT (Drug) $43.70
- Azstarys (Drug) $20.00
- TRINTELLIX (Drug) $14.57
- EMGALITY (Drug) $14.52
- AZSTARYS (Drug) $14.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Eugene
Christopher Worlton, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $3,033
Mr. James Akins, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $2,542
Ms. Amber Benson, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $1,628
Mr. Kenneth Zimmerman, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $1,167
Jeffrey Sperla, Np, NP
Psychiatric/Mental Health — Payments: $1,137
Katherine Leatherman, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $1,097